L&T Technology Services Ltd. share price target

151bps QoQ at 15.2% in Q2 slightly higher than our estimates of 14.7% by 52bps. Management expects margins to further improve in Q4 led by margin levers (utilization, offshore mix, pyramid, attrition) and higher growth in Telecom & Hi-tech segment. Guidance came in line with our estimates of 6.5% (Ple: 6% decline) revenue decline for FY21E. We had released a detailed report in December on ER&D; sector, where we have mention how ER&D; spends will pick up in coming quarters. link Management mentioned that ER&D; spends remains strong across all...

LTTS reported revenue de-growth of -12.5% QoQ USD 3% above our estimates (Ple:10% QoQ, Cons: 12%). Weak revenue growth was on account of steep decline of 22.8% QoQ in transportation vertical & 24.5% decline in...

LTTS reported revenue de-growth of -2.0% QoQ USD 3% below our estimates (Ple:1% QoQ, Cons: 1.2%). Weak revenue growth was on account of steep decline of 8.8% QoQ in plant & engineering. Vertical was impacted by project closures in O&G; segment & we believe this vertical will take longer to revive. Reported EBIT margin at 15.2% was down 160 bps QoQ (Ple/Cons: 17.2%), while adjusted for one-off (contribution to PM CARES fund) was 16.5% (-30 bps QoQ). Margin was impacted by lower revenue but aided by strong currency tailwinds. We expect FY21 margin to be impacted by lower revenue....

L&T; Technology Services' (LTTS) Q4FY20 earnings were mixed beating our revenue estimates but EBITDA and PAT came below our estimates. Consolidated revenue for Q4FY20 stood at Rs 14,466mn registering +7.7% YoY/+1.7% QoQ, EBITDA increased 7.7% YoY/declined 6.3% QoQ to Rs 2,683mn and PAT increased 7.2% YoY/0.2% QoQ to Rs 2,063mn. Constant currency Revenue (USD) stood at $194 million, up by 1.6% YoY/down 2.5% QoQ, due to COVID-19 outbreak as the company faced supply side constraints and demand side challenges resulting in loss of productivity and work from home for employees. EBIT stood at Rs...

We maintain our conviction on LTTS based on (1) Preferred pick in ER&D on diversified vertical mix (low concentration risk) and niche position in Process Industry and Industrial products, (2) At an inflexion point with stability/recovery expected in Telecom & Hi-tech vertical, (3) Strong account mining engine with T30 program (>USD 10mn client bucket had 3 additions QoQ). Expect USD rev/EPS CAGR at 12.5/15.2% over FY19-22E factoring USD rev growth at 10.1/12.2/15.1% and EBIT% at 17.1/17.0/17.5% for FY20/21/22E, respectively. Key risk continues to be macros, trade war escalation (Industrial products vertical). We maintain our BUY on L&T; Tech (LTTS) based on in-line performance, growth bottoming-out in 3Q on strong wins/pipeline and expectation of stability/recovery in Telecom & Hi-tech vertical. Our TP of Rs 1,790 implies 18x Dec-21E EPS (marginal EPS est change).

LTTS continues to outperform ER&D peers, even as near term growth has slowed. We believe this has more to do with macros, and reckon that LTTS is reasonably resilient with its relatively stronger technical capabilities, diversified vertical mix and niche position in Process Industry and Industrial products. We build USD rev/EPS to post 11.5/14.5% CAGR over FY19-22E. That macros can play a bigger spoilsport than now is the only risk. We maintain BUY on LTTS despite the EPS downgrade (~5%) on weak near-term outlook (2Q nos were in-line). While relative outperformance continues, deceleration in growth trajectory limits our optimism. Our TP is Rs 1,705, based on 18x Sep-21E (20x earlier).

Transportation in US and Singapore, 1 deal in Industrial, 1 deal in Hi-tech and 3 deals in Medical). However, weakness in semiconductor space is likely to dent growth prospects. EBITDA margin at 18.5% (excl. IND AS impact) was ahead of estimates (Ple: 17.2%; consensus: 17.8%)....